Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Institute on Aging (R01AG062277)
Renova
Leonard D. Schaeffer Center for Health Policy and Economics
- License Information
-
More Information
Article History
First Online: 24 February 2020
Compliance with Ethical Standards
:
: This study was partly funded by a fellowship from the University of Southern California, Leonard D. Schaeffer Center for Health Policy and Economics, by the National Institute on Aging of the National Institutes of Health under award number R01AG062277, and a contract from Renova Therapeutics to the RAND Corporation. Decisions on research design, interpretation of the findings, and submission were made by the authors; the sponsors did not have a role in any of these decisions.
: Dr. Mattke serves on the Board of Directors of Senscio Systems, Inc. and the scientific advisory board of AiCure Technologies, Boston Millennia Partners, and ZanoZano. He has received consulting fees from Biotronik, Bristol-Myers Squibb, and Defined Health. Jakub P. Hlávka and Asa Wilks report no conflicts of interest. This article has been read and approved by all authors.
